RSS Content

Array BioPharma To Present At The Annual J.P. Morgan Healthcare Conference

BOULDER, Colo., Jan. 2, 2018 /PRNewswire/ -- Array BioPharma Inc. (Nasdaq: ARRY) today announced that its Chief Executive Officer, Ron Squarer, will speak at the Annual J.P. Morgan Healthcare Conference in San Francisco.  The public is welcome to participate in the conference through a webcast on the Array BioPharma website.   


Annual J.P. Morgan Healthcare Conference


Ron Squarer, Chief Executive Officer, Array BioPharma


Monday, January 8, 2018


4:00 p.m. Pacific Time


Westin St. Francis Hotel, San Francisco



Array BioPharma. (PRNewsFoto/Array BioPharma Inc.) (PRNewsFoto/)

About Array BioPharma
Array BioPharma Inc. is a biopharmaceutical company focused on the discovery, development and commercialization of targeted small molecule drugs to treat patients afflicted with cancer.  Nine registration studies are currently advancing related to seven Array-owned or partnered drugs: binimetinib (MEK162), encorafenib (LGX818), selumetinib (partnered with AstraZeneca), danoprevir (partnered with Roche), ipatasertib (partnered with Genentech), larotrectinib (partnered with Loxo Oncology) and tucatinib (partnered with Cascadian Therapeutics).


Tricia Haugeto

Array BioPharma Inc.



Cision View original content with multimedia:

SOURCE Array BioPharma Inc.